Genocea Biosciences, Inc.

GNCACIK 0001457612 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Genocea Biosciences, Inc.

Name	Roles	Filings
Clark William D	OfficerDirector	4
Duvall Diantha	Officer	4
Flechtner Jessica Baker	Officer	4
Aakalu Girish N	Officer	2
Davis Thomas Andrew	Officer	2

Showing 1-5 of 20

Per pagePage 1 of 4Next

All filings

31 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 3, 2022	Clark William D President and CEO · Director	SSale	4,023	$0.06	$241
Jun 3, 2022	Flechtner Jessica Baker Chief Scientific Officer	SSale	1,578	$0.06	$95
Jun 3, 2022	Duvall Diantha CHIEF FINANCIAL OFFICER	SSale	1,355	$0.06	$81
Jun 2, 2022	Clark William D President and CEO · Director	SSale	117,244	$0.0617	$7,234
Jun 2, 2022	Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFF	SSale	2,500	$0.0601	$150

Showing 1-5 of 31

Per pagePage 1 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value